• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微卫星不稳定结直肠癌细胞的免疫逃逸。

Immune evasion of microsatellite unstable colorectal cancers.

机构信息

Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.

出版信息

Int J Cancer. 2010 Sep 1;127(5):1001-10. doi: 10.1002/ijc.25283.

DOI:10.1002/ijc.25283
PMID:20198617
Abstract

Colorectal cancers (CRC) develop through 2 major pathways of genetic instability. In contrast to the majority of CRCs, which are characterized by chromosomal instability, high-level microsatellite unstable (MSI-H) CRCs arise as a consequence of the loss of DNA mismatch repair (MMR) functions and show accumulation of insertion and deletion mutations particularly in microsatellite sequences. MSI-H occurs in about 15% of CRCs, and virtually all CRCs occurring in the context of the hereditary cancer-predisposing Lynch syndrome. These tumors are characterized by a comparably good prognosis and a low frequency of distant metastases. Because of the expression of a defined set of tumor-specific antigens, MSI-H CRCs elicit a strong local and systemic antitumoral immune response of the host and therefore use different strategies to evade the control of the immune system. In this review, we will summarize novel molecular mechanisms that at the same time drive pathogenesis, immunogenicity and immune evasion during the development and progression of MSI-H CRCs. We will focus on the current knowledge about alterations in human leukocyte antigen (HLA) antigen presentation and discuss how immune evasion-while offering protection against local antitumoral immune responses-paradoxically might interfere with the ability of the tumor to form distant organ metastases.

摘要

结直肠癌(CRC)通过 2 种主要的遗传不稳定途径发展。与大多数具有染色体不稳定性的 CRC 不同,高水平微卫星不稳定(MSI-H)CRC 是由于 DNA 错配修复(MMR)功能丧失而产生的,并且表现出插入和缺失突变的积累,特别是在微卫星序列中。MSI-H 发生在约 15%的 CRC 中,几乎所有发生在遗传性癌症易感 Lynch 综合征背景下的 CRC 都是如此。这些肿瘤具有相对较好的预后和低远处转移频率。由于表达一组明确的肿瘤特异性抗原,MSI-H CRC 引发宿主强烈的局部和全身抗肿瘤免疫反应,因此它们使用不同的策略来逃避免疫系统的控制。在这篇综述中,我们将总结同时驱动 MSI-H CRC 发病机制、免疫原性和免疫逃逸的新的分子机制。我们将重点介绍关于人类白细胞抗原(HLA)抗原呈递的改变的最新知识,并讨论免疫逃逸——虽然提供了对局部抗肿瘤免疫反应的保护——如何矛盾地可能干扰肿瘤形成远处器官转移的能力。

相似文献

1
Immune evasion of microsatellite unstable colorectal cancers.微卫星不稳定结直肠癌细胞的免疫逃逸。
Int J Cancer. 2010 Sep 1;127(5):1001-10. doi: 10.1002/ijc.25283.
2
Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes.微卫星不稳定结直肠癌中 HLA II 类抗原表达缺失是由 HLA II 类调节基因的突变引起的。
Int J Cancer. 2010 Aug 15;127(4):889-98. doi: 10.1002/ijc.25106.
3
Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.林奇综合征合并微卫星不稳定结直肠癌患者血清中针对移码肽的抗体。
Fam Cancer. 2010 Jun;9(2):173-9. doi: 10.1007/s10689-009-9307-z.
4
Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases.结直肠癌中的微卫星不稳定性与局部淋巴细胞浸润及远处转移低发生率相关。
Br J Cancer. 2005 May 9;92(9):1746-53. doi: 10.1038/sj.bjc.6602534.
5
High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer.高内皮静脉与结直肠癌的微卫星不稳定性、遗传背景和免疫逃逸有关。
Br J Cancer. 2019 Aug;121(5):395-404. doi: 10.1038/s41416-019-0514-6. Epub 2019 Jul 30.
6
Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers.微卫星不稳定型结直肠癌中的免疫选择压力和人类白细胞抗原I类抗原机制缺陷
Cancer Res. 2005 Jul 15;65(14):6418-24. doi: 10.1158/0008-5472.CAN-05-0044.
7
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.致癌作用与微卫星不稳定性:遗传学与表观遗传学之间的相互关系。
Carcinogenesis. 2008 Apr;29(4):673-80. doi: 10.1093/carcin/bgm228. Epub 2007 Oct 17.
8
Role of the microenvironment in the tumourigenesis of microsatellite unstable and MUTYH-associated polyposis colorectal cancers.微环境在微卫星不稳定和 MUTYH 相关息肉病结直肠癌肿瘤发生中的作用。
Mutagenesis. 2012 Mar;27(2):247-53. doi: 10.1093/mutage/ger077.
9
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.遗传性非息肉病性结直肠癌(HNPCC)与散发性微卫星不稳定型结肠癌在导致HLA I类表达缺失方面遵循不同途径。
BMC Cancer. 2007 Feb 22;7:33. doi: 10.1186/1471-2407-7-33.
10
Relationship between genetic alterations and prognosis in sporadic colorectal cancer.散发性结直肠癌中基因改变与预后的关系。
Int J Cancer. 2006 Apr 1;118(7):1721-7. doi: 10.1002/ijc.21563.

引用本文的文献

1
Identification of Common Cancer Antigens Useful for Specific Immunotherapies to Colorectal Cancer and Liver Metastases.鉴定对结直肠癌和肝转移瘤特异性免疫疗法有用的常见癌症抗原。
Int J Mol Sci. 2025 Jul 31;26(15):7402. doi: 10.3390/ijms26157402.
2
Perspectives of Targeting Autophagy as an Adjuvant to Anti-PD-1/PD-L1 Therapy for Colorectal Cancer Treatment.将自噬作为辅助抗PD - 1/PD - L1疗法用于结直肠癌治疗的前景
Cells. 2025 May 20;14(10):745. doi: 10.3390/cells14100745.
3
Peptide-MHC I regulatory mechanisms and intervention strategies in anti-tumor T cell immunity.
肽-MHC I在抗肿瘤T细胞免疫中的调节机制及干预策略
Acta Pharmacol Sin. 2025 May 16. doi: 10.1038/s41401-025-01574-y.
4
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions.癌症免疫疗法的进展:历史回顾、当前发展及未来方向。
Mol Cancer. 2025 May 7;24(1):136. doi: 10.1186/s12943-025-02305-x.
5
Predicting the Efficacy of Immune Checkpoint Inhibitors in Esophageal Cancer: Changes in Peripheral Blood Lymphocyte Subsets Before and After Immunotherapy.预测免疫检查点抑制剂在食管癌中的疗效:免疫治疗前后外周血淋巴细胞亚群的变化
Cancer Manag Res. 2025 Apr 16;17:815-825. doi: 10.2147/CMAR.S503171. eCollection 2025.
6
ImmuneLENS characterizes systemic immune dysregulation in aging and cancer.免疫透镜(ImmuneLENS)可表征衰老和癌症中的全身免疫失调。
Nat Genet. 2025 Mar;57(3):694-705. doi: 10.1038/s41588-025-02086-5. Epub 2025 Feb 18.
7
Resistance mechanisms to immune checkpoint inhibitors: updated insights.免疫检查点抑制剂的耐药机制:最新见解
Mol Cancer. 2025 Jan 15;24(1):20. doi: 10.1186/s12943-024-02212-7.
8
Loss of Heterozygosity (LOH) Affecting HLA Genes in Breast Cancer: Clinical Relevance and Therapeutic Opportunities.乳腺癌中影响HLA基因的杂合性缺失(LOH):临床相关性与治疗机遇
Genes (Basel). 2024 Nov 28;15(12):1542. doi: 10.3390/genes15121542.
9
Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the :c.1528C>T South African Founder Variant.携带:c.1528C>T南非始祖变异的林奇综合征同质性队列中基因多态性对癌症诊断年龄的影响。
Biomedicines. 2024 Sep 27;12(10):2201. doi: 10.3390/biomedicines12102201.
10
Target therapy of TIGIT; a novel approach of immunotherapy for the treatment of colorectal cancer.TIGIT的靶向治疗;一种用于治疗结直肠癌的新型免疫治疗方法。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):231-241. doi: 10.1007/s00210-024-03346-7. Epub 2024 Aug 19.